In our study, ECH stimulated the browning of 3T3-L1 adipocytes via the activation of DRD1/5, suggesting that dopaminergic receptors could be an alternative target for anti-obesity drugs in the adipose tissue. The gene discussed is DRD1; the disease is Obesity.